Titan Biotech Ltd manufacturer and exporter of the Biological productsBusiness Overview: TBL is an ISO 9001:2008 Certified & cGMP facilitated manufacturer & exporter of biological products used in the fields of Pharmaceutical, Nutraceutical, Food & Beverages, Biotechnology & Fermentation, Cosmetic, Veterinary & Animal Feed, Agriculture Industries, Microbiology Culture Media &...
Titan Biotech Limited has announced the publication of its unaudited financial results for the quarter ended June 30, 2025. The company has fulfilled its disclosure requirements by advertising these results in Financial Express (English) and Naya India (Hindi) newspapers. This makes the latest financial performance data readily available to the...
Titan Biotech Limited is entering arbitration with NGenious Solutions Private Limited over a dispute concerning an ERP software upgrade. NGenious claims outstanding dues for services that Titan Biotech asserts were deficient, containing errors and bugs. As a result, the company terminated the agreement and withheld payments. NGenious is seeking Rs....
Titan Biotech Limited is facing arbitration proceedings from NGenious Solutions Private Limited, seeking recovery of outstanding dues. The claim totals approximately 0.106 Crore, covering principal, accrued interest, and compensation. This action names the company, its directors, and key management personnel. This material litigation represents a financial dispute that, if settled...
Titan Biotech has announced a certificate confirming that all securities received for dematerialization during the quarter have been processed—accepted or rejected—and listed on relevant stock exchanges. The physical share certificates have been verified, mutilated, and canceled, with ownership updated in the registrar’s records within 15 days. This ensures smooth and...
Titan Biotech Limited has announced a board meeting to consider the financial results for the quarter and half-year. The company published audited financial results in major newspapers and on its website, ensuring transparency for shareholders. This step underscores the company’s commitment to timely financial disclosure and keeps investors informed about...
